ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2021

Preclinical Evaluation of an Engineered Single-Chain Fragment Variable-Fragment Crystallizable Targeting Human CD44.

Philipp Diebolder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.